Immunicon Alternatives & Competitors
12 companies similar to Immunicon — Pioneering cell-based diagnostic solutions to empower physicians with timely and...
Companies similar to Immunicon
Sopherion Therapeutics
Innovating metastatic breast cancer treatment through advanced nanotechnology solutions.
Pathwork Diagnostics
Pioneering molecular diagnostics for oncology with the first FDA-cleared microarray-based...
Polaris Biology
Meet the next resolution in medicine
Shanghai, China
Adaptive Biotechnologies Corp.
Every immune system has a story to tell; the key is knowing how to listen.
Seattle, United States
Rival Readout
Competing with Immunicon? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
ANGLE
The leading experts in cancer cell capture and analysis from liquid biopsies
United Kingdom
LungLife AI
LungLife AI is transforming lung cancer diagnosis and management through AI-enabled analys...
Thousand Oaks, United Sta...
Metabolomx
Breath analysis technology that detects lung cancer with high accuracy, identifying subtyp...
VG Life Sciences
Developing lifesaving therapies for drug-resistant cancers and autoimmune diseases through...
Inmedix Inc
Bringing accurate and safe HRV meeting FDA standards to clinicians.
United States
Zymeron Corporation
Zymeron is a research-based biotechnology company that innovates and commercializes health...
Durham, United States
OncoRes Medical
Transforming the standard of care in breast cancer surgery.
Australia
CryptoMedix
Pioneering therapeutic advancements in cancer and inflammatory diseases by targeting uniqu...
About Immunicon
Immunicon, a pioneer in cell-based diagnostic solutions, is revolutionizing the field of cancer diagnosis and treatment. The company's flagship product, CellTracks, enables the identification, counting, and characterization of tumor cells in blood samples, providing crucial insights to physicians and scientists at an e...
Cell-based Diagnostics, Cancer Insights, Diagnostic Products, Cancer Research, Clinical Practices, Tumor Cell Identification, Blood Sample Analysis, FDA Approval Process, Collaboration With Johnson & Johnson, Metastatic Breast Cancer Management, Cancer Drug Development, Cardiovascular Diseases, Infectious Diseases, Medical Technology, Healthcare Innovation
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Immunicon: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Immunicon on 21 Jun 2024. The 12 companies listed here were last checked between 26 Jul 2024 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
